Well let me start off by saying I was way way off of the number GITS actually ended up with last weekend for its opener. Yikes! so I thought it might open to 37 million and end up at 80 million but that is completely not in the cards for this movie. In my previous post about this I speculated about the whitewashing controversy with the film and that Scar-Jo was playing with fire by taking the role from an Asian actress. There may be something to this as of the three films (Dr. Strange and Great Wall) that were mentioned this one was considered the most grievous. Mostly because it’s an adaptation of an Japanese anime film and it takes place in Tokyo and according to the film hardly anyone lives there that is actually Japanese. In fact the spoiler apparently makes the case of whitewashing even more plain. But as this is not a review don’t worry I won’t reveal that here. It is possible that audiences had no appetite for sci-fi. Sony’s Life, a sci-fi horror movie fared equally badly. Perhaps it will make it back in the international arena where it is already at 92.8 million. I would imagine that’s still a pretty weak number as it looks like most of the major countries are accounted for here. So for a movie that cost over 100 million to finance it looks like Paramount will take a pretty costly hit for this one. The website Independent claims Paramount admits this is probably going to happen to the tune of at least 60 million. Ouch!!

For last weekend the Boss Baby with Alec Baldwin kicked everyone’s ass including Beauty and the Beast, Ghost in the Shell, Kong: Skull Island and Logan. The Baby made 50 million dollars for number 1 and it put March over a Billion; $1,148,058,562 which puts this year as 53 million more than last year at this time. Man March is starting to look a lot like summer these days.

Titan Vs. Titan Comics

Titan vs. Titan Comics is an independent collective specializing in historical and sci-fi storylines. We take pride in producing a well-crafted comic book in all aspects of the process, from conception to production.